Teva Pharmaceutical Industries competitive analysis

Explore patent oppositions filed by Teva Pharmaceutical Industries against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jun 25, 2026
Patent NumberTitleApplicantOpposition Date
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKApr 19, 2026
Methods Of Treating Fabry Patients Having Renal ImpairmentAMICUS THERAPEUTICSApr 15, 2026
Stabilizing Camptothecin Pharmaceutical CompositionsIPSEN BIOPHARMApr 7, 2026
New Combination Of Active Agents For The Treatment Of Progressive Fibrosing Interstitial Lung Diseases (Pf-Ild)BOEHRINGER INGELHEIMApr 2, 2026
Compositions And Methods For The Treatment Of Graft Versus Host DiseaseVECTIVBIOApr 2, 2026
New Oral Pharmaceutical Composition And Dose Regimen For The Therapy Of Progressive Fibrosing Interstitial Lung DiseasesBOEHRINGER INGELHEIMApr 2, 2026
Starting Dose Of Pth ConjugatesASCENDIS PHARMA BONE DISEASESApr 1, 2026
Pharmaceutical Composition Containing Poorly-Soluble Basic MedicineCHUGAI SEIYAKU KABUSHIKI KAISHAMar 18, 2026
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSMar 10, 2026
Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTISNov 21, 2025

Explore Teva Pharmaceutical Industries's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jun 25, 2026
Patent NumberPublication DateTitleTotal Oppositions
Mar 13, 2024Medical Injection Device Packaging2
Mar 22, 2017Process For Manufacturing A Pharmaceutical Preparation Containing Glatiramer Acetate2

Latest PTAB cases involving Teva Pharmaceutical Industries

Discover the latest PTAB cases involving Teva Pharmaceutical Industries, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Teva Pharmaceutical Industries with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jun 25, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
TEVA PHARMACEUTICALS218201712
BOEHRINGER INGELHEIM3321489
JANSSEN PHARMACEUTICA173 - 1
NOVARTIS6521 - 21